MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
Consolidators: BioPharmaceuticals
Boehringer Ingelheim International GmbH
Finance & Acquisitions: Boehringer Ingelheim
Parents
Boehringer Ingelheim International GmbH
Children
2016: AbbVie Bolsters Immunology Business, Acquires Boehringer Drug
2023: Boehringer Ingelheim expands immuno-oncology portfolio with the acquisition of bacterial cancer therapy specialist T3 Pharma
2024: Boehringer Acquires Nerio with Its Novel Checkpoint Inhibitors for $1.3B
2025: Tempus Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline
Nerio Therapeutics
T3 Pharmaceuticals
ViraTherapeutics
Jumps
*Key People: Boehringer Ingelheim
Organization & Developments: Boehringer Ingelhelm